These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 28111985)
21. Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system. Guleria RS; Choudhary R; Tanaka T; Baker KM; Pan J J Cell Physiol; 2011 May; 226(5):1292-307. PubMed ID: 20945395 [TBL] [Abstract][Full Text] [Related]
22. Controlling cardiomyocyte length: the role of renin and PPAR-{gamma}. Hinrichs S; Heger J; Schreckenberg R; Wenzel S; Euler G; Arens C; Bader M; Rosenkranz S; Caglayan E; Schlüter KD Cardiovasc Res; 2011 Feb; 89(2):344-52. PubMed ID: 20884641 [TBL] [Abstract][Full Text] [Related]
23. Dual peroxisome-proliferator-activated-receptor-α/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction. Kalliora C; Kyriazis ID; Oka SI; Lieu MJ; Yue Y; Area-Gomez E; Pol CJ; Tian Y; Mizushima W; Chin A; Scerbo D; Schulze PC; Civelek M; Sadoshima J; Madesh M; Goldberg IJ; Drosatos K JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31393858 [TBL] [Abstract][Full Text] [Related]
24. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches. Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972 [TBL] [Abstract][Full Text] [Related]
25. PPAR agonists for the treatment of cardiovascular disease in patients with diabetes. Wilding JP Diabetes Obes Metab; 2012 Nov; 14(11):973-82. PubMed ID: 22443197 [TBL] [Abstract][Full Text] [Related]
26. Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1. Guo Z; Liao Z; Huang L; Liu D; Yin D; He M Eur J Pharmacol; 2015 Aug; 761():245-53. PubMed ID: 26086862 [TBL] [Abstract][Full Text] [Related]
27. Conjugated linoleic acid prevents high glucose-induced hypertrophy and contractile dysfunction in adult rat cardiomyocytes. Aloud BM; Raj P; O'Hara K; Shao Z; Yu L; Anderson HD; Netticadan T Nutr Res; 2016 Feb; 36(2):134-42. PubMed ID: 26826429 [TBL] [Abstract][Full Text] [Related]
28. The role of oxidative stress in high glucose-induced apoptosis in neonatal rat cardiomyocytes. Zhou X; Lu X Exp Biol Med (Maywood); 2013 Aug; 238(8):898-902. PubMed ID: 23788170 [TBL] [Abstract][Full Text] [Related]
29. Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension. Tsai HC; Li TH; Huang CC; Huang SF; Liu RS; Yang YY; Hsieh YC; Lee KC; Huang YH; Hou MC; Lin HC Am J Pathol; 2018 Jul; 188(7):1608-1624. PubMed ID: 29929914 [TBL] [Abstract][Full Text] [Related]
31. No evidence of QT prolongation with supratherapeutic doses of aleglitazar. Sturm S; Bentley D; Jordan P; Russell-Yarde F; Ruf T J Cardiovasc Pharmacol; 2012 Mar; 59(3):288-97. PubMed ID: 22113345 [TBL] [Abstract][Full Text] [Related]
32. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439 [TBL] [Abstract][Full Text] [Related]
33. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2. Yang H; Mao Y; Tan B; Luo S; Zhu Y Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858 [TBL] [Abstract][Full Text] [Related]
34. The effect of aleglitazar on the pharmacokinetics and pharmacodynamics of S- and R-warfarin in healthy male subjects. Sanwald-Ducray P; Jamois C; Banken L J Cardiovasc Pharmacol; 2014 Feb; 63(2):152-7. PubMed ID: 24157957 [TBL] [Abstract][Full Text] [Related]
35. PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects. Kim MK; Chae YN; Choi SH; Moon HS; Son MH; Bae MH; Choi HH; Hur Y; Kim E; Park YH; Park CS; Kim JG; Lim JI; Shin CY Eur J Pharmacol; 2011 Jan; 650(2-3):673-81. PubMed ID: 20974124 [TBL] [Abstract][Full Text] [Related]
36. The antioxidant edaravone prevents cardiac dysfunction by suppressing oxidative stress in type 1 diabetic rats and in high-glucose-induced injured H9c2 cardiomyoblasts. Ji L; Liu Y; Zhang Y; Chang W; Gong J; Wei S; Li X; Qin L Can J Physiol Pharmacol; 2016 Sep; 94(9):996-1006. PubMed ID: 27376621 [TBL] [Abstract][Full Text] [Related]
37. Peroxisome Proliferator-Activated Receptor-α Inhibition Protects Against Doxorubicin-Induced Cardiotoxicity in Mice. Rahmatollahi M; Baram SM; Rahimian R; Saeedi Saravi SS; Dehpour AR Cardiovasc Toxicol; 2016 Jul; 16(3):244-50. PubMed ID: 26082188 [TBL] [Abstract][Full Text] [Related]
38. Aleglitazar, a dual PPARα and PPARγ agonist for the potential oral treatment of type 2 diabetes mellitus. Lecka-Czernik B IDrugs; 2010 Nov; 13(11):793-801. PubMed ID: 21046527 [TBL] [Abstract][Full Text] [Related]
39. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II. He Z; Zhang X; Chen C; Wen Z; Hoopes SL; Zeldin DC; Wang DW Cardiovasc Res; 2015 Mar; 105(3):304-17. PubMed ID: 25618409 [TBL] [Abstract][Full Text] [Related]
40. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats. El Midaoui A; Wu L; Wang R; de Champlain J Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]